BU-NOT-SET

CONTACT US
Is outsourcing the most viable pathway for innovators?
  • Manufacturing
Meeting
Insight
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
  • Drug product
Two lab workers
Case study
Recipharm Wins two 2020 CMO Leadership Awards
  • Industry trends
Eyes
Insight
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
  • Corporate
Eyes
Insight
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
  • Manufacturing
Eyes
Insight
Recipharm 25 years
  • Corporate
24 years
Brochure
API product list
  • Drug substance
white pills
Fact sheet
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
  • Drug substance
Eyes
Insight
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
  • Industry trends
Eyes
Insight
Insight
  • Drug product
Safely scaling high potency API manufacturing
eBook
  • Development
  • Drug product
A predictive approach to complex OSD development
Video
  • Development
Predictable development for uneventful manufacturing
Insight
  • Biologics
  • Drug product
Building Better RNA Medicines Through Smarter LNP Formulation
Insight
  • Drug product
Evolving strategies in oral solid dosage development
Case study
  • Sustainability
Sustainable pharmaceutical packaging
Webinar
  • Drug product
  • Manufacturing
Webinar | Bringing High Potent Drugs to Market
White paper
  • Drug product
  • Development
IVPT Strategies for reliable bioequivalence assessment
White paper
  • Biologics
  • Manufacturing
Recipharm Advanced Bio Is Advancing Optimizing TFF for RNA